Market Snapshot: Dow briefly gains foothold on 27,000, S&P 500 erases this year's losses on vaccine hopes, Goldman earnings

U.S. stocks rose at the start of Wednesday's trade, on optimism about progress on a COVID-19 vaccine candidate despite rising U.S. cases, while investors are digesting earnings reports and monitoring U.S.-China tensions.